Generate MHC Class Research Articles

MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis.

Oligodendrocytes and their progenitors upregulate MHC pathways in response to inflammation, but the frequency of this phenotypic change is unknown and the features of these immune oligodendroglia are poorly defined. We generated MHC class I and II transgenic reporter mice to define their dynamics in response to inflammatory demyelination, providing a means to monitor MHC activation in diverse cell types in living mice and define their roles in aging, injury, and disease.

MEDB-47. CD4+ T cells restrict medulloblastoma growth and dissemination

The immune system serves as a powerful defense not only against pathogens and parasites but also against neoplastic cells. Emerging immunotherapies that boost the activity of tumor-reactive immune cells or counteract immune suppressive mechanisms have shown promising effects in certain cancer types. However, the success of immunotherapy for brain tumors has been limited, highlighting the need for a better understanding of the immune microenvironment. Our preliminary studies have shown that T cells critically affect tumor growth in mouse models of the pediatric brain tumor medulloblastoma. In particular, depletion of CD4+ T cells results in more aggressive growth of medulloblastoma cells and allows these cells to metastasize to the spinal cord. To test whether CD4+ T cells can recognize and attack tumor cells directly, we generated MHC class II knockout tumors. Surprisingly, depletion of CD4+ cells still enhanced tumor growth and metastasis. These results suggest that CD4+ T cells regulate medulloblastoma growth independently of MHC II on tumor cells. We hypothesized that CD4+ T cell may not directly kill tumor cells but recruit and activate another effector immune cell type that eliminates tumor cells. As CD4+ T cells have a well-studied helper function for CD8+ T cells, we examined whether their anti-tumoral function relies on the activation of cytotoxic CD8+ T cells. The depletion of CD4+ T cells still resulted in advanced growth of MHC class I-deficient, and thus CD8+ T cell resistant, tumor cells indicating that CD4+ T cells counteract tumor growth in a CD8+ T cell-independent manner. Ongoing studies are aimed at elucidating the mechanisms by which CD4+ T cells regulate medulloblastoma growth, including the antigen-presenting cells that activate them and the effector cells responsible for killing tumor cells. These studies will advance our understanding of the immune microenvironment in medulloblastoma and allow us to design more effective therapies.

Making Insulin and Staying Out of Autoimmune Trouble: The Beta-Cell Conundrum

Autoimmune type 1 diabetes (T1D) results from the intricate crosstalk of various immune cell types. CD8+ T cells dominate the pro-inflammatory milieu of islet infiltration (insulitis), and are considered as key effectors of beta-cell destruction, through the recognition of MHC Class I-peptide complexes. The pathways generating MHC Class I-restricted antigens in beta cells are poorly documented. Given their specialized insulin secretory function, the associated granule processing and degradation pathways, basal endoplasmic reticulum stress and susceptibility to additional stressors, alternative antigen processing and presentation (APP) pathways are likely to play a significant role in the generation of the beta-cell immunopeptidome. As direct evidence is missing, we here intersect the specificities of beta-cell function and the literature about APP in other cellular models to generate some hypotheses on APPs relevant to beta cells. We further elaborate on the potential role of these pathways in T1D pathogenesis, based on the current knowledge of antigens presented by beta cells. A better understanding of these pathways may pinpoint novel mechanisms amenable to therapeutic targeting to modulate the immunogenicity of beta cells.

Deubiquitinating Enzyme UCH-L1 Promotes Dendritic Cell Antigen Cross-Presentation by Favoring Recycling of MHC Class I Molecules.

The deubiquitinating enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) is required for the maintenance of axonal integrity in neurons and is thought to regulate the intracellular pool of ubiquitin in the brain. In this study, we show that UCH-L1 has an immunological function in dendritic cell (DC) Ag cross-presentation. UCH-L1 is expressed in mouse kidney, spleen, and bone marrow-derived DCs, and its expression and activity are regulated by the immune stimuli LPS and IFN-γ. UCH-L1-deficient mice have significantly reduced ability to cross-prime CD8 T cells in vivo and in vitro because of a reduced ability of DCs to generate MHC class I (MHC I) peptide complexes for cross-presented Ags. Mechanistically, Ag uptake by phagocytosis and receptor-mediated endocytosis as well as phagosome maturation are unaffected by loss of UCH-L1 in DCs. Rather, MHC I recycling is reduced by loss of UCH-L1, which affects the colocalization of intracellular MHC I with late endosomal/lysosomal compartments necessary for cross-presentation of Ag. These results demonstrate a hitherto unrecognized role of the deubiquitinating enzyme UCH-L1 in DC Ag processing.

Batf3-dependent Dendritic Cells are Required to Present Cell-associated Antigen to CD4 T Cells

Abstract Dendritic cells (DCs) are required to prime T cells during an immune response. The dogma in the field is that Batf3-dependent DCs (DC1s) prime CD8 T cells and IRF4-dependent DCs (DC2s) prime CD4 T cells. However, recent studies have shown that DC1s are required for induction of Th1 immune responses and to prime autroreactive CD4 T cells in the NOD mouse model of diabetes. Therefore, this segregation of priming theory is flawed. To further study the contribution of DC1s to CD4 T cell priming, we generated an XCR1-cre mouse and crossed it to the MHC class II floxed mouse to generate MHC class II deficient DC1s. We found that the form of antigen directs the priming of T cells. DC2s are superior at presenting soluble antigen as evidenced by normal CD4 and CD8 OVA specific T cell responses in mice lacking DC1s. However, DC1s are superior at presenting cell-associated antigen as evidenced by a lack of OVA specific CD4 and CD8 T cell priming in mice lacking DC1s. Furthermore, CD4 priming during tumor immune responses is absent when DC1s lack MHC class II. Our findings show that the DC subsets differ in the form of antigen that they present. DC1s present cell-associated material; whereas DC2s present soluble antigen.

Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands.

CD8+ T cell immunosurveillance is based on recognizing oligopeptides presented by MHC class I molecules. Despite decades of study, the importance of protein ubiquitylation to peptide generation remains uncertain. In this study, we examined the ability of MLN7243, a recently described ubiquitin-activating enzyme E1 inhibitor, to block overall cytosolic peptide generation and generation of specific peptides from vaccinia- and influenza A virus-encoded proteins. We show that MLN7243 rapidly inhibits ubiquitylation in a variety of cell lines and can profoundly reduce the generation of cytosolic peptides. Kinetic analysis of specific peptide generation reveals that ubiquitylation of defective ribosomal products is rate limiting in generating class I peptide complexes. More generally, our findings demonstrate that the requirement for ubiquitylation in MHC class I-restricted Ag processing varies with class I allomorph, cell type, source protein, and peptide context. Thus, ubiquitin-dependent and -independent pathways robustly contribute to MHC class I-based immunosurveillance.

Sa1758 In Vitro Adalimumab Exposure Decreases RORγT Expressing and RORγT/FoxP3 Double Expressing T-Lymphocytes From Peripheral Blood of Crohn's Disease Patients: A Study of Th17 Plasticity in Response to Anti-TNF

G A A b st ra ct s recognizing E. coli OmpC. Methods: Tetramer-guided epitope mapping (TGEM) in HLADR*1501 subjects consistently identified a single T cell epitope in OmpC for use in tetramerbased assays. Direct ex vivo characterization was performed by staining with PE-labeled tetramers against OmpC and Flu peptides and subsequent enrichment with anti-PE magnetic beads. Cells were stained for surface markers and analyzed by flow cytometry. Frequency of antigen-specific T cells was calculated as the number of post-enrichment tetramer+ cells/ total pre-enrichment CD4+ cells. Results: The frequency of OmpC-specific T cells was 9.1 (+/-2)/million CD4+ T cells (n=26) compared to 13.7 (+/-2)/million Flu-specific T cells (n= 17), p=.18. The majority of both Flu and OmpC-specific T cells expressed a memory T cell phenotype (CD45RA-). There were no regulatory T cells (CD25+CD127-) identified among OmpC or Flu-specific CD4s. A high percentage of OmpC-specific T cells expressed the guthoming marker, a4b7, compared to Flu-specific T cells (44%+/-2 vs. 13.7% +/-2, p<.0001). Expression of the Th17 marker, CD161, was more frequent on OmpC than Flu-specific T cells (38.5 %+/-5 vs. 13% +/-2, p <.0001). While there was some expression of the Th1 marker, CXCR3, on OmpC-specific T cells, this was less than was expressed by Flu-specific T cells (27%+/-4 vs. 50% +/-5, p= .0015). The current study was underpowered to detect differences in frequency or phenotype among OmpC seropositive and seronegative CD subjects and healthy controls. OmpC-specific T cells identified above were isolated for future RNA transcript analyses to reveal qualitative differences in these cells between patients with and without CD. Conclusions: We have identified T cell epitopes for E.coli OmpC in HLADR *1501 subjects and generated MHC class II tetramers that identify OmpC-specific T cells. OmpC-specific T cells have a frequency similar to Flu-specific T cells and bear a distinct phenotype. They are memory T cells with gut-homing integrin a4b7 expression. They lack Treg markers and express mixed Th1 and Th17 markers. These data confirm that healthy humans and CD subjects harbor commensal-specific T cells and suggest that active suppression of T cell responses is lost in subjects with CD.

Sa1757 Targeting Innate Immune Receptors to Treat Inflammatory Bowel Disease: Preclinical Activity of IMO-9200, an Antagonist of TLRS 7, 8, and 9 in Mouse Models of Colitis

G A A b st ra ct s recognizing E. coli OmpC. Methods: Tetramer-guided epitope mapping (TGEM) in HLADR*1501 subjects consistently identified a single T cell epitope in OmpC for use in tetramerbased assays. Direct ex vivo characterization was performed by staining with PE-labeled tetramers against OmpC and Flu peptides and subsequent enrichment with anti-PE magnetic beads. Cells were stained for surface markers and analyzed by flow cytometry. Frequency of antigen-specific T cells was calculated as the number of post-enrichment tetramer+ cells/ total pre-enrichment CD4+ cells. Results: The frequency of OmpC-specific T cells was 9.1 (+/-2)/million CD4+ T cells (n=26) compared to 13.7 (+/-2)/million Flu-specific T cells (n= 17), p=.18. The majority of both Flu and OmpC-specific T cells expressed a memory T cell phenotype (CD45RA-). There were no regulatory T cells (CD25+CD127-) identified among OmpC or Flu-specific CD4s. A high percentage of OmpC-specific T cells expressed the guthoming marker, a4b7, compared to Flu-specific T cells (44%+/-2 vs. 13.7% +/-2, p<.0001). Expression of the Th17 marker, CD161, was more frequent on OmpC than Flu-specific T cells (38.5 %+/-5 vs. 13% +/-2, p <.0001). While there was some expression of the Th1 marker, CXCR3, on OmpC-specific T cells, this was less than was expressed by Flu-specific T cells (27%+/-4 vs. 50% +/-5, p= .0015). The current study was underpowered to detect differences in frequency or phenotype among OmpC seropositive and seronegative CD subjects and healthy controls. OmpC-specific T cells identified above were isolated for future RNA transcript analyses to reveal qualitative differences in these cells between patients with and without CD. Conclusions: We have identified T cell epitopes for E.coli OmpC in HLADR *1501 subjects and generated MHC class II tetramers that identify OmpC-specific T cells. OmpC-specific T cells have a frequency similar to Flu-specific T cells and bear a distinct phenotype. They are memory T cells with gut-homing integrin a4b7 expression. They lack Treg markers and express mixed Th1 and Th17 markers. These data confirm that healthy humans and CD subjects harbor commensal-specific T cells and suggest that active suppression of T cell responses is lost in subjects with CD.

Sa1756 The Renin-Angiotensin System Promotes Colitis Independently of Blood Pressure

G A A b st ra ct s recognizing E. coli OmpC. Methods: Tetramer-guided epitope mapping (TGEM) in HLADR*1501 subjects consistently identified a single T cell epitope in OmpC for use in tetramerbased assays. Direct ex vivo characterization was performed by staining with PE-labeled tetramers against OmpC and Flu peptides and subsequent enrichment with anti-PE magnetic beads. Cells were stained for surface markers and analyzed by flow cytometry. Frequency of antigen-specific T cells was calculated as the number of post-enrichment tetramer+ cells/ total pre-enrichment CD4+ cells. Results: The frequency of OmpC-specific T cells was 9.1 (+/-2)/million CD4+ T cells (n=26) compared to 13.7 (+/-2)/million Flu-specific T cells (n= 17), p=.18. The majority of both Flu and OmpC-specific T cells expressed a memory T cell phenotype (CD45RA-). There were no regulatory T cells (CD25+CD127-) identified among OmpC or Flu-specific CD4s. A high percentage of OmpC-specific T cells expressed the guthoming marker, a4b7, compared to Flu-specific T cells (44%+/-2 vs. 13.7% +/-2, p<.0001). Expression of the Th17 marker, CD161, was more frequent on OmpC than Flu-specific T cells (38.5 %+/-5 vs. 13% +/-2, p <.0001). While there was some expression of the Th1 marker, CXCR3, on OmpC-specific T cells, this was less than was expressed by Flu-specific T cells (27%+/-4 vs. 50% +/-5, p= .0015). The current study was underpowered to detect differences in frequency or phenotype among OmpC seropositive and seronegative CD subjects and healthy controls. OmpC-specific T cells identified above were isolated for future RNA transcript analyses to reveal qualitative differences in these cells between patients with and without CD. Conclusions: We have identified T cell epitopes for E.coli OmpC in HLADR *1501 subjects and generated MHC class II tetramers that identify OmpC-specific T cells. OmpC-specific T cells have a frequency similar to Flu-specific T cells and bear a distinct phenotype. They are memory T cells with gut-homing integrin a4b7 expression. They lack Treg markers and express mixed Th1 and Th17 markers. These data confirm that healthy humans and CD subjects harbor commensal-specific T cells and suggest that active suppression of T cell responses is lost in subjects with CD.

Outer membrane proteins preferentially load MHC class II peptides: Implications for a Chlamydia trachomatis T cell vaccine

CD4 T cell immune responses such as interferon-γ and tumor necrosis factor-α secretion are necessary for Chlamydia immunity. We used an immunoproteomic approach in which Chlamydia trachomatis and Chlamydia muridarum-derived peptides presented by MHC class II molecules on the surface of infected dendritic cells (DCs) were identified by tandem mass spectrometry using bone marrow derived DCs (BMDCs) from mice of different MHC background. We first compared the C. muridarum immunoproteome in C3H mice to that previously identified in C57BL/6 mice. Fourteen MHC class II binding peptides from 11 Chlamydia proteins were identified from C3H infected BMDCs. Two C. muridarum proteins overlapped between C3H and C57B/6 mice and both were polymorphic membrane proteins (Pmps) which presented distinct class II binding peptides. Next we studied DCs from C57BL/6 mice infected with the human strain, C. trachomatis serovar D. Sixty MHC class II binding peptides derived from 27 C. trachomatis proteins were identified. Nine proteins were orthologous T cell antigens between C. trachomatis and C. muridarum and 2 of the nine were Pmps which generated MHC class II binding epitopes at distinct sequences within the proteins. As determined by antigen specific splenocyte responses outer membrane proteins PmpF, -G and -H and the major outer membrane protein (MOMP) were antigenic in mice previously infected with C. muridarum or C. trachomatis. Furthermore a recombinant protein vaccine consisting of the four Pmps (PmpEFGH) with MOMP formulated with a Th1 polarizing adjuvant significantly accelerated (p<0.001) clearance in the C57BL/6 mice C. trachomatis transcervical infection model. We conclude that Chlamydia outer membrane proteins are important T cell antigens useful in the development of a C. trachomatis subunit vaccine.

AB0043 Regulatory Function of Natural Killer Cells in Systemic Lupus Erythematosus (SLE)

BackgroundNatural killer (NK) cells are large granular lymphocytes that belong to the innate immunity. The activation or inhibition of NK cells is regulated by several membrane receptors, commonly designated as...

Antigen specificity of tuberculosis-specific CD4+ T cells in IKEPLUS immunized mice (P3122)

Abstract Mycobacterium tuberculosis (Mtb) infects one-third of the global population. A more efficacious vaccine is urgently needed for control and prevention of disease. We recently reported a genetically modified strain of M. smegmatis, IKEPLUS, which is a promising vaccine candidate due to its ability to generate an unprecedented level of bactericidal immunity against Mtb in mice. Since protective immunity induced by IKEPLUS is dependent on antigen-specific CD4+ T cell memory, we hypothesized that specificity of the CD4+ T cell response was critical for protection. To determine CD4+ T cell specificity directly, we generated MHC class II (I-Ab) restricted T cell hybridomas from IKEPLUS-immunized mice. Screening of T cell hybridomas against anion exchange-fractionated IKEPLUS and Mtb proteins provided evidence for multiple specific targets, one of which was identified as the AtpA protein, a product of the Mtb Rv1308 gene. In a complementary approach, using in vitro assays of IFNγ production by splenocytes from IKEPLUS-immunized mice, we identified an immunogenic peptide within the Mtb RplJ protein encoded by the Rv0651 gene. Our results demonstrate the CD4+ T cell response in IKEPLUS-immunized mice has multiple targets, among which AtpA and RplJ represent novel specificities for protective responses against Mtb. Further studies to more fully define the range of specificities of CD4+ T cells in IKEPLUS-immunized mice should help to inform the design of effective vaccines against Mtb.

Immunodeficiency and Autoimmunity in H2-O–Deficient Mice

HLA-DO/H2-O is a highly conserved, nonpolymorphic MHC class II-like molecule expressed in association with H2-M in thymic epithelial cells, B lymphocytes, and primary dendritic cells. The physiological function of DO remains unknown. The finding of cell maturation-dependent DO expression in B lymphocytes and dendritic cells suggests the possibility that H2-O functions to promote the presentation of exogenous Ag by attenuating presentation of endogenous self-peptides. In the current study, we report that H2-O(-/-) mice spontaneously develop high titers of IgG2a/c antinuclear Abs (ANAs) with specificity for dsDNA, ssDNA, and histones. Reconstitution of RAG1(-)(/)(-) mice with T and B cells from H2-O(-)(/)(-) or wild-type mice demonstrated that production of ANAs requires participation of CD4(+) T cells from H2-O(-)(/)(-) mice. Bone marrow chimeras demonstrated that loss of H2-O expression in thymic epithelial cells did not induce ANAs, and that lack of H2-O expression in bone marrow-derived cells was sufficient to induce the autoimmune phenotype. Despite production of high titers of autoantibodies, H2-O(-/-) mice exhibit a delayed generation of humoral immunity to model Ags (OVA and keyhole limpet hemocyanin), affecting all major T-dependent Ig classes, including IgG2a/c. Ag presentation experiments demonstrated that presentation of exogenous Ag by H2-O(-/-) APC was inefficient as compared with wild-type APC. Thus, H2-O promotes immunity toward exogenous Ags while inhibiting autoimmunity. We suggest that H2-O, through spatially or temporally inhibiting H2-M, may enhance presentation of exogenous Ag by limiting newly generated MHC class II molecules from forming stable complexes with endogenous self-peptides.

MHC Class II immunoproteomic analysis of Chlamydia trachomatis and C. muridarum infected murine dendritic cells reveals overlapping immunodominant epitopes (106.7)

Abstract Protective immunity to Chlamydia is T cell-mediated, requiring MHC class II presented antigens. Immunodominant T cell antigens are potential human Chlamydia vaccine candidates. An immunoproteomic approach was undertaken in which Chlamydia-derived peptides presented by MHC class II molecules on the surface of infected murine dendritic cells (DCs) were identified by tandem mass spectrometry. DCs from both Balb/c and C57BL/6 mice were infected with C. muridarum and DCs from C57BL/6 were infected with C. trachomatis and C. muridarum. DCs from Balb/c infected with C. muridarum yielded 14 MHC class II binding peptides from 11 different C. muridarum proteins. Only one of the 11 proteins was shared in common with 16 C. muridarum proteins that generated MHC class II binding peptides using DCs from C57BL/6 mice. However, C57BL/6 DCs infected with C. trachomatis serovar D yielded 60 MHC class II binding peptides derived from 27 proteins, 10 of which were shared between the C. muridarum and C. trachomatis proteome. Among the 10 overlapping proteins six were tested for protective immunity and all conferred protection in mice against C. muridarum genital tract infection using DDA/MPL adjuvant. Three of the protective proteins belonged to the polymorphic membrane family of proteins, which generated MHC binding epitopes at distinct sequences within the proteins. We conclude that T cell immunodominance is determined by both MHC allelic selection and inherent properties of pathogen proteins.

Grand Challenges in Molecular Antigen-presenting Cell Biology

SPECIALTY GRAND CHALLENGE article Front. Immunol., 21 March 2011Sec. Antigen Presenting Cell Biology volume 2 - 2011 | https://doi.org/10.3389/fimmu.2011.00008

NF-κB, and not MYCN, Regulates MHC Class I and Endoplasmic Reticulum Aminopeptidases in Human Neuroblastoma Cells

Neuroblastoma (NB) is the most common solid extracranial cancer of childhood. Amplification and overexpression of the MYCN oncogene characterize the most aggressive forms and are believed to severely downregulate MHC class I molecules by transcriptional inhibition of the p50 NF-kappaB subunit. In this study, we found that in human NB cell lines, high MYCN expression is not responsible for low MHC class I expression because neither transfection-mediated overexpression nor small interfering RNA suppression of MYCN affects MHC class I and p50 levels. Furthermore, we identified NF-kappaB as the immediate upstream regulator of MHC class I because the p65 NF-kappaB subunit binds MHC class I promoter in chromatin immunoprecipitation experiments, and MHC class I expression is enhanced by p65 transfection and reduced by (a) the chemical NF-kappaB inhibitor sulfasalazine, (b) a dominant-negative IKBalpha gene, and (c) p65 silencing. Moreover, we showed that the endoplasmic reticulum aminopeptidases ERAP1 and ERAP2, which generate MHC class I binding peptides, are regulated by NF-kappaB, contain functional NF-kappaB-binding elements in their promoters, and mimic MHC class I molecules in the expression pattern. Consistent with these findings, nuclear p65 was detected in NB cells that express MHC class I molecules in human NB specimens. Thus, the coordinated downregulation of MHC class I, ERAP1, and ERAP2 in aggressive NB cells is attributable to a low transcriptional availability of NF-kappaB, possibly due to an unknown suppressor other than MYCN.

The tumour-suppressor p53 is not required for pancreatic beta cell death during diabetes and upon irradiation.

Immune-independent diabetes often occurs via pancreatic beta cell dysfunction. However, the role of the tumour suppressor p53 that regulates cellular life and death in multiple tissues, in pancreatic cell death and diabetes has not been clarified. We have therefore utilized an established mouse model for diabetes in which the MHC class I antigen is overexpressed in pancreatic beta cells under the rat insulin promoter, to investigate the role of p53. We show that pancreatic beta cell death, as determined by TUNEL staining, is elevated in transgenic mice compared to wild-type mice. However, there was no increase in immuno-reactivity towards anti-p53 antibodies in the pancreas of transgenic mice over the course of diabetes formation and beta cell death, suggesting that p53 may not be involved in these processes. Interestingly, p53 expression was also not induced in pancreas upon gamma-irradiation, which resulted in a massive increase in the number of TUNEL-positive cells, suggesting that the p53 pathway may not be causally involved in pancreatic cell death. To further confirm these findings, we generated MHC class I transgenic mice lacking p53 expression. Absence of p53 did not result in any significant changes in pancreatic morphology or affect cell death levels. Importantly, p53 absence did not rescue the diabetic phenotype of the transgenic mice. The results therefore demonstrate that p53 may not be causally involved in pancreatic beta cell death, and suggests that the classical cell death pathway dependent on p53 may not be operating in pancreatic beta cells.

Intracellular Cysteine Residues in the Tail of MHC Class I Proteins Are Crucial for Extracellular Recognition by Leukocyte Ig-Like Receptor 1

The activity of NK cells is regulated by activating receptors that recognize mainly stress-induced ligands and by inhibitory receptors that recognize mostly MHC class I proteins on target cells. Comparing the cytoplasmic tail sequences of various MHC class I proteins revealed the presence of unique cysteine residues in some of the MHC class I molecules which are absent in others. To study the role of these unique cysteines, we performed site specific mutagenesis, generating MHC class I molecules lacking these cysteines, and demonstrated that their expression on the cell surface was impaired. Surprisingly, we demonstrated that these cysteines are crucial for the surface binding of the leukocyte Ig-like receptor 1 inhibitory receptor to the MHC class I proteins, but not for the binding of the KIR2DL1 inhibitory receptor. In addition, we demonstrated that the cysteine residues in the cytoplasmic tail of MHC class I proteins are crucial for their egress from the endoplasmic reticulum and for their palmitoylation, thus probably affecting their expression on the cell surface. Finally, we show that the cysteine residues are important for proper extracellular conformation. Thus, although the interaction between leukocyte Ig-like receptor 1 and MHC class I proteins is formed between two extracellular surfaces, the intracellular components of MHC class I proteins play a crucial role in this recognition.

Analysis of the Role of Bleomycin Hydrolase in Antigen Presentation and the Generation of CD8 T Cell Responses

Long oligopeptides (>10 residues) are generated during the catabolism of cellular proteins in the cytosol. To be presented to T cells, such peptides must be trimmed by aminopeptidases to the proper size (typically 8-10 residues) to stably bind to MHC class I molecules. Aminopeptidases also destroy epitopes by trimming them to even shorter lengths. Bleomycin hydrolase (BH) is a cytosolic aminopeptidase that has been suggested to play a key role in generating MHC class I-presented peptides. We show that BH-deficient cells from mice are unimpaired in their ability to present epitopes from N-extended precursors or whole Ags and express normal levels of MHC class I molecules. Similarly, BH-deficient mice develop normal CD8(+) T cell responses to eight epitopes from three different viruses in vivo. Therefore, BH by itself is not essential for the generation or destruction of MHC class I peptides. In contrast, when BH(-/-) mice are crossed to mice lacking another cytosolic aminopeptidase, leucine aminopeptidase, the resulting BH(-/-)leucine aminopeptidase(-/-) progeny show a selective increase in CD8(+) T cell responses to the gp276 epitope from lymphocytic choriomeningitis virus, whereas the ability to present and respond to several other epitopes is unchanged. Therefore, BH does influence presentation of some Ags, although its role is largely redundant with other aminopeptidases.

Generation of MHC class I-presented peptides in cells over-expressing a dominant interfering ubiquitin (B43)

Abstract The participation of the proteasome in MHC class I-restricted antigen processing is well documented, but the degree to which targeting of antigenic proteins to this multicatalytic protease is ubiquitin-dependent remains unclear. To address this question, we over-expressed wild type ubiquitin (Ub-WT) and lysineless ubiquitin (Ub-K0) in mammalian cells using an inducible vaccinia system. Compared to Ub-WT, the Ub-K0 potently abrogated the conjugation of ubiquitin to protein substrates, and subsequently attenuated total protein degradation. In co-infection assays, the Ub-K0 significantly inhibited specific epitope presentation from cytosolic N-end Rule substrates and an exocytic model antigen, but had little effect on antigen presentation from a stable cytosolic antigen. Interestingly, the inhibitory effect on antigen presentation by Ub-K0 decreased when the exocytic model antigen is directed to the cytoplasm, and increased when the stable cytosolic antigen is directed to the endoplasmic reticulum (ER). Despite similar levels of surface MHC class I molecules, different peptide profiles bound to surface class I molecules were observed from cells over-expressing Ub-WT and Ub-K0. The results suggest that cytosolic proteins and glycoproteins may be targeted to proteasome through different pathways to generate MHC class I peptides. This study is supported by NIH grant AI39501.